Production & Manufacturing
OTC

OTC

Valeant to divest iNova Pharmaceuticals for $930m By PBR Staff Writer
Valeant Pharmaceuticals International has agreed to divest its iNova Pharmaceuticals business for around $930m.
Production & Manufacturing > OTC > News
Fresenius Kabi agrees to acquire Akorn for $4.3bn By PBR Staff Writer
German healthcare firm Fresenius Kabi has agreed to acquire US prescription and over-the-counter (OTC) pharmaceutical products manufacturer Akorn for around $4.3bn.
Production & Manufacturing > OTC > News Sanofi agrees to divest five OTC products to Ipsen for EUR83m By PBR Staff Writer
Sanofi has agreed to divest five of its over-the-counter consumer healthcare products in Europe to French pharma firm Ipsen for €83m.
Production & Manufacturing > OTC > News
See more OTC news

Latest OTC News and Insight